PreAnalytiX GmbH, formed by QIAGEN N.V. and BD, has introduced the PAXgene Urine Liquid Biopsy Set for analyzing cell-free DNA in urine using various molecular testing technologies like qPCR, digital PCR, and NGS. QIAGEN will commercialize the new...
AstraZeneca, a worldwide biopharmaceutical company focused on science, declared that FluMist is now the sole self-administered flu vaccine approved in the United States. FluMist, a nasal spray without needles, was authorized for...
Prime Minister Narendra Modi declared assistance of USD 7.5 million in sampling kits, detection kits, and vaccines for nations combatting cervical cancer. Addressing the Cancer Moonshot event in Delaware, Modi stressed India's dedication to...
Leading pharmaceutical company Lupin Limited has revealed a non-exclusive patent license agreement with Takeda Pharmaceutical Company Limited to sell vonoprazan tablets in India. Lupin will be launching their new drug, Lupivon, in two different...
The Organisation for Rare illnesses India (ORDI) and St John's Medical College and Hospital have signed a Memorandum of Understanding (MoU) to help children with rare kidney illnesses and their families. These include about 150 rare illnesses...
While India anticipates the Union Budget 2024, the pharmaceutical industry in India is looking forward to initiatives that will improve their expansion and reinforce India's standing as a global leader. At present, the pharmaceutical industry is...
The first generic raltegravir medications for treating adult and pediatric HIV patients weighing at least 40kg have been authorized by the UK Medicines and Healthcare products Regulatory Agency (MHRA). HIV is responsible for AIDS, which...
Renalys Pharma, Inc. reported the dosing of the initial participant in its phase III clinical trial of sparsentan for IgA nephropathy treatment in Japan. Renalys submitted an Investigational New Drug (IND) Application for sparsentan to the...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has given the green light for the medication vibegron (Obgemsa) to address symptoms of overactive bladder (OAB) syndrome in adult patients. Indications might consist of a sudden...
The increasing prevalence of neurological disorders is fueling market expansion, as there is a shift towards manufacturing radiopharmaceuticals utilizing cyclotron technology. Yet, challenges arise due to issues with preparing and distributing...
, CDSCO.jpg)
